|
CN111983055A
|
|
Method for separating and measuring rivaroxaban intermediate related substances by using HPLC (high performance liquid chromatography)
|
|
CN111983054A
|
|
Method for separating and measuring related substances of empagliflozin intermediate by using HPLC (high performance liquid chromatography)
|
|
CN111983056A
|
|
Method for separating and measuring related substances of tofacitinib intermediate by using HPLC (high performance liquid chromatography)
|
|
CN111999400A
|
|
Method for separating and determining impurities of bulk drugs of baricitinib by using HPLC (high performance liquid chromatography)
|
|
CN111253346A
|
|
Synthetic method for preparing empagliflozin intermediate
|
|
CN111411116A
|
|
Ketoreductase, nucleic acid, recombinant expression plasmid and strain, and application in synthesis of Laolatinib intermediate
|
|
CN109374782A
|
|
A method of with the related substance of the net bulk pharmaceutical chemicals of HPLC separation determination Yi Palie
|
|
CN109374784A
|
|
A method of with the related substance of HPLC separation determination Dapagliflozin bulk pharmaceutical chemicals
|
|
CN109374783A
|
|
A method of with the related substance of HPLC separation determination canagliflozin bulk pharmaceutical chemicals
|
|
CN109295020A
|
|
Ketoreductase and its application in synthesis (1S) -2- chloro- 1- (3,4- difluorophenyl) ethyl alcohol
|
|
CN109295021A
|
|
Ketoreductase and its application in bis- (trifluoromethyl) benzyl carbinols of asymmetric syntheses R-3,5-
|
|
CN108018026A
|
|
A kind of dust inhibitor and preparation method thereof
|
|
CN107904269A
|
|
A kind of method that engineering strain conversion prepares (S) (+) 3 hydroxyl tetrahydrofuran
|
|
CN108220261A
|
|
Ketoreductase, nucleic acid, recombinant expression carrier, recombinant strains and application
|
|
CN106053665A
|
|
Method for measuring related substances in ipragliflozin proline bulk pharmaceutical chemicals through HPLC separation
|
|
CN105777719A
|
|
Synthesis method of Daclatasvir
|
